Home / Directory / Regulatory Affairs & Submissions / UDI Management Platform

Regulatory Affairs & Submissions · Healthcare & Life Sciences

Should you build or buy UDI Management Platform?

UDI Management platforms help medical device manufacturers comply with unique device identification requirements by managing UDI-DI and UDI-PI data across their product portfolio, submitting device records to the FDA's GUDID database and EU's EUDAMED registry, and maintaining labeling data in conformance with FDA 21 CFR Part 830 and EU MDR/IVDR labeling rules. They are essentially a regulatory data management system for the device identifier that must accompany every device to market.

The build-vs-buy decision for UDI Management turns on how well FDA GUDID and EU EUDAMED's well-defined schemas map to your existing product data infrastructure, and how far AI-assisted data entry and PLM-native submission approaches have come at covering the regulatory submission wrapper; whether your product hierarchy lives in a structured PLM often decides it.

Build it, buy it, or bridge?

⚒ Build it
✓ Buy it
➔ Bridge
Cost shape
Low if product data already lives in structured PLM; submission wrapper is the build cost
Per-SKU or per-product pricing; predictable but scales with portfolio size
License platform for submission and labeling management; extend for PLM data sync
Time to value
Weeks if PLM integration exists; longer if product hierarchy needs restructuring first
Fast deployment for standard portfolios; configuration complexity grows with product variation
Platform handles authority submissions immediately; PLM sync customization follows
Differentiation captured
None on UDI compliance; potential advantage in cleaner PLM-to-registry data flow
Compliance outcome identical; vendor handles multi-country submission variant logic
Same compliance output; bridge value is tighter integration with existing product data systems
AI feasibility today
AI-assisted data entry and submission pipelines are increasingly viable; structured data problem is tractable
Vendors adding AI for automated data population and label change detection
AI-assisted PLM-to-GUDID data mapping is the most practical extension point for bridge approach
Who it fits
Medtech companies with well-structured PLM and in-house regulatory engineering; single-region compliance
Most device makers, especially with broad portfolios and multi-country EUDAMED obligations
Companies wanting automatic PLM-to-registry sync without replacing the compliance submission layer

When building makes sense

Building UDI management internally makes the most sense when your product data already lives in a well-structured PLM or ERP system and the vendor platform would be adding primarily a submission wrapper around data you already own and maintain. The underlying data problem is more tractable than most regulatory software — FDA GUDID and EU EUDAMED schemas are well-defined, AI-assisted data entry has reduced the manual effort of populating UDI records, and some medtech companies already run custom submission scripts from PLM exports for straightforward single-region filings. The build case strengthens when your product hierarchy doesn't map cleanly to what a vendor platform expects, making configuration as expensive as custom development anyway, or when you have in-house regulatory engineering staff who can maintain the submission pipeline against periodic authority schema updates.

When buying makes sense

Buying makes sense for most device manufacturers, particularly those with broad product portfolios and multi-country regulatory obligations spanning GUDID, EUDAMED, and additional regional registries. The vendor platforms in this space — Greenlight Guru, Rimsys, MasterControl, and DDi Visu UDI — handle the variation between authority-specific submission formats and labeling rule requirements across markets, which is operationally complex to maintain internally. Buying also makes sense when your product data isn't already structured in a way that supports clean automated submission — vendor platforms include data entry workflows, labeling management, and audit trails that a self-built system would need to replicate. For companies where UDI compliance is a checkbox rather than a strategic differentiator, a vendor platform delivers complete coverage without infrastructure investment.

The desk read

FDA GUDID and EU EUDAMED schemas are well-defined, which means the underlying data problem in UDI management is more tractable than most regulatory software. Platforms like Greenlight Guru, Rimsys, and MasterControl bundle UDI-DI registration, labeling management, and GUDID submission into a compliance workflow that most medtech teams can deploy without deep configuration. That buy case is strongest for companies with broad product portfolios and multi-country regulatory obligations.

AI-assisted data entry and submission pipelines have made partial self-building more viable than it was three years ago. Some medtech companies already manage UDI internally through PLM or ERP extensions with custom submission scripts, particularly when their product hierarchy doesn't map cleanly to what a vendor platform expects. The build case gets serious when a company's product data already lives in a well-structured PLM and the vendor platform would primarily be adding a submission wrapper around data the company already owns and maintains.

Representative vendors RimsysMasterControl + 3 more, scored in Pro

Frequently asked

What is a UDI Management Platform?

UDI Management platforms help medical device manufacturers comply with unique device identification requirements by managing UDI-DI and UDI-PI data, submitting device records to the FDA's GUDID database and EU's EUDAMED registry, and maintaining labeling data in conformance with FDA 21 CFR Part 830 and EU MDR/IVDR labeling rules.

When does building a UDI Management Platform make sense?

Building makes sense when your product data already lives in a well-structured PLM or ERP and the vendor platform would primarily be adding a submission wrapper around data you already own. AI-assisted data entry and custom submission scripts from PLM exports have made single-region self-builds increasingly practical for teams with regulatory engineering staff.

When does buying a UDI Management Platform make sense?

Buying makes sense for most device manufacturers, especially those with broad portfolios and multi-country GUDID and EUDAMED obligations. Vendor platforms handle the variation between authority-specific submission formats across markets, which is operationally complex to maintain internally without dedicated regulatory engineering.

What are the main UDI Management Platform vendors?

Representative vendors include Rimsys, DDi (Visu UDI), MasterControl, Greenlight Guru. B4 Pro scores the full set.

What is the difference between UDI-DI and UDI-PI?

UDI-DI (Device Identifier) is the fixed portion of the UDI that identifies the device version or model — it's what gets submitted to GUDID and EUDAMED as a permanent record. UDI-PI (Production Identifier) is the variable portion that encodes lot or batch number, serial number, manufacture date, and expiration date on individual device labels. UDI management platforms typically handle both the static DI registry submissions and the labeling rules that govern how PI data appears on device packaging.

The B4 Index scores every software category on two axes, strategic differentiation and AI feasibility, to classify it Build, Buy, Bridge, or Beware. See the full methodology.